Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial

Agarwal, 2003, Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States, Am J Med, 115, 291, 10.1016/S0002-9343(03)00366-8

Zoccali, 1998, Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients, Kidney Int, 53, 1078, 10.1111/j.1523-1755.1998.00853.x

Amar, 1997, Influence of nycthemeral blood pressure pattern in treated hypertensive patients on hemodialysis, Kidney Int, 51, 1863, 10.1038/ki.1997.254

Agarwal, 2010, Hypervolemia is associated with increased mortality among hemodialysis patients, Hypertension, 56, 512, 10.1161/HYPERTENSIONAHA.110.154815

Agarwal, 2009, Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial, Hypertension, 53, 500, 10.1161/HYPERTENSIONAHA.108.125674

Blankestijn, 2004, Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications, Semin Dial, 17, 265, 10.1111/j.0894-0959.2004.17324.x

Heerspink, 2009, Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials, Lancet, 373, 1009, 10.1016/S0140-6736(09)60212-9

Agarwal, 2009, Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis, Hypertension, 53, 860, 10.1161/HYPERTENSIONAHA.108.128116

Lindholm, 2002, Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, Lancet, 359, 1004, 10.1016/S0140-6736(02)08090-X

Devereux, 1986, Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings, Am J Cardiol, 57, 450, 10.1016/0002-9149(86)90771-X

Agarwal, 1999, Supervised atenolol therapy in the management of hemodialysis hypertension, Kidney Int, 55, 1528, 10.1046/j.1523-1755.1999.00359.x

Agarwal, 2001, Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses, Am J Kidney Dis, 38, 1245, 10.1053/ajkd.2001.29221

Li, 2006, The epidemiology of systolic blood pressure and death risk in hemodialysis patients, Am J Kidney Dis, 48, 606, 10.1053/j.ajkd.2006.07.005

Kalantar-Zadeh, 2005, Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions, Hypertension, 45, 811, 10.1161/01.HYP.0000154895.18269.67

Zannad, 2006, Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies, Kidney Int, 70, 1318, 10.1038/sj.ki.5001657

Cice, 2003, Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial, J Am Coll Cardiol, 41, 1438, 10.1016/S0735-1097(03)00241-9

Lang, 1995, Attenuation of isoproterenol-mediated vasodilatation in blacks, N Engl J Med, 333, 155, 10.1056/NEJM199507203330304

Stein, 2000, Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks. Additive mechanisms leading to enhanced vascular reactivity, Hypertension, 36, 945, 10.1161/01.HYP.36.6.945

Weir, 1998, Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives, Hypertension, 31, 1088, 10.1161/01.HYP.31.5.1088

Chrysant, 1979, Racial differences in pressure, volume and renin interrelationships in essential hypertension, Hypertension, 1, 136, 10.1161/01.HYP.1.2.136

Converse, 1992, Sympathetic overactivity in patients with chronic renal failure, N Engl J Med, 327, 1912, 10.1056/NEJM199212313272704

Zoccali, 2002, Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease, Circulation, 105, 1354, 10.1161/hc1102.105261